Other OTC Pharmaceuticals (Pharmacies) - Poland

  • Poland
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$0.47bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.04%, resulting in a market volume of US$0.52bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$11.57 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Poland has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Poland have played a crucial role in its growth. Consumers in Poland have shown a strong preference for self-medication and over-the-counter products. This preference can be attributed to several factors, including the convenience and accessibility of OTC products, as well as the increasing awareness and knowledge of consumers regarding their own health. Additionally, the rising healthcare costs in Poland have also encouraged consumers to opt for OTC pharmaceuticals as a more affordable alternative to prescription medications. Trends in the market have further fueled the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Poland. One notable trend is the increasing demand for natural and herbal remedies. Consumers are increasingly seeking out OTC products that are perceived as more natural and have fewer side effects. This trend is in line with the global shift towards natural and organic products in the healthcare industry. Pharmacies in Poland have responded to this trend by expanding their offerings of natural and herbal OTC products, which has further boosted the market's growth. Another trend in the market is the growing popularity of online pharmacies. With the increasing use of e-commerce platforms and the convenience of online shopping, more consumers in Poland are turning to online pharmacies to purchase their OTC pharmaceuticals. This trend has been accelerated by the COVID-19 pandemic, which has led to an increased reliance on online shopping for healthcare products. As a result, online pharmacies have experienced significant growth in Poland, contributing to the overall expansion of the Other OTC Pharmaceuticals (Pharmacies) market. Local special circumstances in Poland have also played a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a well-established healthcare system with a strong network of pharmacies. Pharmacies in Poland are easily accessible to consumers, with a high density of pharmacies in both urban and rural areas. This accessibility has made it convenient for consumers to purchase OTC pharmaceuticals, contributing to the market's growth. Underlying macroeconomic factors have also influenced the development of the Other OTC Pharmaceuticals (Pharmacies) market in Poland. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among consumers. This higher disposable income has allowed consumers to spend more on healthcare products, including OTC pharmaceuticals. Additionally, the aging population in Poland has also contributed to the market's growth, as older individuals tend to have a higher demand for OTC medications. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Poland has been growing due to customer preferences for self-medication, trends in the market such as the demand for natural remedies and the rise of online pharmacies, local special circumstances including the accessibility of pharmacies, and underlying macroeconomic factors such as economic growth and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)